{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:12:58Z","timestamp":1788970378119,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.anndiagpath.2026.152708","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:23:16Z","timestamp":1787325796000},"page":"152708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinicopathological analysis of 110 cases of SMARCA4-deficient conventional non-small cell lung cancer"],"prefix":"10.1016","volume":"85","author":[{"given":"Huifang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.anndiagpath.2026.152708_bb0005","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/ng.2628","article-title":"Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human malignancy","volume":"45","author":"Kadoch","year":"2013","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.anndiagpath.2026.152708_bb0010","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1158\/1535-7163.MCT-21-0433","article-title":"SMARCA4: implications of an altered chromatin-remodeling gene for cancer development and therapy","volume":"20","author":"Mardinian","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.anndiagpath.2026.152708_bb0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.anndiagpath.2016.10.006","article-title":"SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens","volume":"26","author":"Herpel","year":"2017","journal-title":"Ann Diagn Pathol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2026.152708_bb0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00428-017-2148-5","article-title":"SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1(neg)\/CK7(pos)\/HepPar-1(pos) immunophenotype","volume":"471","author":"Agaimy","year":"2017","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152708_bb0025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5858\/arpa.2019-0633-OA","article-title":"SMARCA4\/BRG1-deficient non-small cell lung carcinomas: a case series and review of the literature","volume":"145","author":"Nambirajan","year":"2021","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.anndiagpath.2026.152708_bb0030","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/gcc.20068","article-title":"Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4\/BRG1, in lung tumors","volume":"41","author":"Medina","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.anndiagpath.2026.152708_bb0035","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jtho.2020.01.002","article-title":"Clinicopathologic characteristics of BRG1-deficient NSCLC","volume":"15","author":"Dagogo-Jack","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"13","key":"10.1016\/j.anndiagpath.2026.152708_bb0040","doi-asserted-by":"crossref","first-page":"14171","DOI":"10.1002\/cam4.6083","article-title":"Clinical characteristics and prognostic analysis of SMARCA4-deficient non-small cell lung cancer","volume":"12","author":"Liang","year":"2023","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152708_bb0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.21037\/tlcr-24-567","article-title":"SMARCA4\/BRG1-deficient non-small cell lung cancer: clinical, imaging, pathological features, and follow-up results of 23 patients","volume":"14","author":"Wumener","year":"2025","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152708_bb0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4132\/jptm.2021.09.16","article-title":"TTF1-positive SMARCA4\/BRG1 deficient lung adenocarcinoma","volume":"56","author":"Mehta","year":"2022","journal-title":"J Pathol Transl Med"},{"issue":"7","key":"10.1016\/j.anndiagpath.2026.152708_bb0055","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jtho.2021.03.024","article-title":"SMARCA4 and other SWItch\/Sucrose NonFermentable family genomic alterations in NSCLC: clinicopathologic characteristics and outcomes to immune checkpoint inhibition","volume":"16","author":"Alessi","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.anndiagpath.2026.152708_bb0060","article-title":"Thoracic SMARCA4-deficient tumors: a clinicopathological analysis of 52 cases with SMARCA4-deficient non-small cell lung cancer and 20 cases with thoracic SMARCA4-deficient undifferentiated tumor","volume":"12","author":"Zhou","year":"2024","journal-title":"PeerJ"},{"issue":"2","key":"10.1016\/j.anndiagpath.2026.152708_bb0065","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jtho.2019.10.023","article-title":"SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas","volume":"15","author":"Rekhtman","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152708_bb0070","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/his.15063","article-title":"NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumour: facts and controversies","volume":"84","author":"Yoshida","year":"2024","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.anndiagpath.2026.152708_bb0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/JTO.0b013e31823815d3","article-title":"\u0394Np63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach","volume":"7","author":"Pelosi","year":"2012","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2026.152708_bb0080","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/modpathol.2011.173","article-title":"p40 (\u0394Np63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma","volume":"25","author":"Bishop","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2026.152708_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.156241","article-title":"Clinicopathological features of SMARCA4-deficient non-small cell lung cancer","volume":"275","author":"Han","year":"2025","journal-title":"Pathol Res Pract"},{"issue":"21","key":"10.1016\/j.anndiagpath.2026.152708_bb0090","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1158\/1078-0432.CCR-20-1825","article-title":"The genomic landscape of SMARCA4 alterations and associations with outcomes in patients with lung cancer","volume":"26","author":"Schoenfeld","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.anndiagpath.2026.152708_bb0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jmoldx.2017.11.004","volume":"20","author":"Lindeman","year":"2018","journal-title":"J Mol Diagn"},{"issue":"2","key":"10.1016\/j.anndiagpath.2026.152708_bb0100","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1158\/2159-8290.CD-21-0248","article-title":"Smarca4 inactivation promotes lineage-specific transformation and early metastatic features in the lung","volume":"12","author":"Concepcion","year":"2022","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152708_bb0105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1158\/2159-8290.CD-16-0127","article-title":"Role of KEAP1\/NRF2 and TP53 mutations in lung squamous cell carcinoma development and radiation resistance","volume":"7","author":"Jeong","year":"2017","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.anndiagpath.2026.152708_bb0110","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.annonc.2020.02.017","article-title":"Clinicopathological and genomic correlates of programmed cell death ligand 1 (PD-L1) expression in nonsquamous non-small-cell lung cancer","volume":"31","author":"Lamberti","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.anndiagpath.2026.152708_bb0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.lungcan.2022.05.001","article-title":"SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophils","volume":"169","author":"Velut","year":"2022","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.anndiagpath.2026.152708_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063237","article-title":"Treatment of thoracic SMARCA4-deficient undifferentiated tumors: where we are and where we will go","volume":"25","author":"Longo","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.anndiagpath.2026.152708_bb0125","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.cllc.2022.03.005","article-title":"Efficacy of immune checkpoint inhibitors in SMARCA4-deficient thoracic tumor","volume":"23","author":"Shinno","year":"2022","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.anndiagpath.2026.152708_bb0130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.lungcan.2017.03.015","article-title":"Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas","volume":"108","author":"Schilsky","year":"2017","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.anndiagpath.2026.152708_bb0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1200\/JCO.2008.17.0043","article-title":"Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma","volume":"27","author":"Anagnostou","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152708_bb0140","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1186\/s12885-019-5792-0","article-title":"Thyroid transcription factor-1 as a prognostic indicator for stage IV lung adenocarcinoma with and without EGFR-sensitizing mutations","volume":"19","author":"Park","year":"2019","journal-title":"BMC Cancer"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913426001048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913426001048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:31:48Z","timestamp":1788967908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913426001048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":28,"alternative-id":["S1092913426001048"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2026.152708","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological analysis of 110 cases of SMARCA4-deficient conventional non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2026.152708","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152708"}}